Feb 20 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- HY TOTAL REVENUE FROM ORDINARY ACTIVITIES DOWN 33.03% TO A$360.3M
- HY PROFIT ATTRIBUTABLE DOWN 80.48% TO A$25.4M
- DECLARED INTERIM DIVIDEND OF 7.00 AU CENTS PER SHARE
News: ACL Australian Clinical Labs Says HY Total Revenue From Ordinary Activities Down 33.03% To...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.82 |
Change
-0.010(0.35%) |
Mkt cap ! $555.7M | |||
| Open | High | Low | Value | Volume |
| $2.83 | $2.83 | $2.81 | $9.064K | 3.214K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 25693 | $2.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.83 | 3013 | 7 |
View Market Depth
| Last trade - 10.07am 29/07/2025 (20 minute delay) ? |
| ACL (ASX) Chart |